维普期刊资源整合服务平台（V6.5）

278篇 您的检索式：作者名="ROSENSON RS"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	前蛋白转化酶枯草溶菌素9变异、低密度脂蛋白胆固醇与神经认知功能损害的关系显示文摘尽管之前的研究引发了对抑制前蛋白转化酶枯草溶菌素9(proprotein convertase subtilisin/kexintype9,PCSK9)造成神经认知功能损害事件的关注,但近期一个第3期随机试验并没有发现药物性PCSK9抑制与神经认知损害有关。	黄洁叶鹏 Mefford MT Rosenson RS Cushman M Farkouh ME McClure LA Wadley VG Irvin MR Bittner VA Safford MM Somaratne R Monda KL Muntner P Levitan EB	2017	中华高血压杂志2017，25，12：	2
2	Pluripotenial machanisms of cardioproteotion with HMGCOA reductase inhibitor therapy 显示文摘	Rosenson RS	2001	Am J Cardiovasc Drugs2001，1，6：	1
3	Inhibition of proinflammatory cytokine production by pravastatin显示文摘	Rosenson RS Tangney CC Casey LC	2005	Lancet2005，353，9157：	1
4	Utility of inflammatory markers in the management of coronary artery disease显示文摘	Rosenson RS Koeing W	2003	Am J Cardiol2003，92，1：	1
5	Phospholipase a2 enzymes and the risk of atherosclerosis显示文摘	Rosenson RS Hurt-Camejo E	2012	Eur Heart J2012，33，23：	1
6	Utility of inflammatory markers in the management of coronary artery disease 显示文摘	Rosenson RS Koenig W	2003	Am J Cardiol2003，92，1：	1
7	An tiatherothrombtic propertises of statins: implications for cardiovascular event reduction显示文摘	Rosenson RS Tangney CC	1998	JAMA1998，279，：	1
8	Inhibition of proinflammatory cytokine production by pravastatin 显示文摘	Rosenson RS Tangney CE Casev LC	1999	Lancet1999，353，9157：	1
9	Effects of varespladibmethyl on biomarkers and major caixliovascular events in acutecoronary syndrome patients显示文摘	Rosenson RS Hislop C Elliott M	2010	J Am Coll Cardiol2010，56，14：	1
10	Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-Ⅰ) trial显示文摘	Rosenson RS Otvos JD Freedman DS		0，，：	1
11	Biological basis for statin therapy in stroke prevention显示文摘	Rosenson RS	2000	Curr Opin Neurol2000，13，1：	1
12	Biological basis for statin therapy in stroke prevention 显示文摘	Rosenson RS	2000	Curr Opin Neurol2000，13，：	1
13	Biological basis for statin therapy in stroke prevention显示文摘	Rosenson RS	2000	Curr Opin Neurol2000，13，1：	1
14	Antiatherothrombolic properties of statins: Implications for cardiovascular event reduction显示文摘	Rosenson RS Tangney CC	1998	JAMA1998，279，：	1
15	HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events 显示文摘	Rosenson RS Brewer HB Jr Chapman MJ	2011	Clin Chem2011，57，3：	1
16	Modulation of oxidative stress,inflammation,and atherosclerosis by lipoprotein-associated phospholipase A2显示文摘	Rosenson RS Stafforini DM		0，，09：	1
17	Importance of endothelial function in mediating the benefits of lipid-lowering therapy显示文摘		1998	Am J Cardiol1998，82，10：	1
18	Antiathero thrombotic properties of statins : implications for cardiovaseular event reduection 显示文摘	Rosenson RS Jhngney CC	1998	JAMA1998，279，20：	1
19	Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone:a retrospective data analysis显示文摘	Rosenson RS Fernandes AW	2004	Clin Ther2004，26，9：	1
20	Biological basis for stain therapy in stroke prevention显示文摘		2000	Curr Opin Neurol2000，13，1：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示